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tention towards screening of these patient groups are un-
dertaken. An enhanced understanding of multilevel aneu-
rysm disease can probably improve the general care of this
patient group.
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Objectives: When abdominal aortic aneurysms (AAA)
and common iliac artery (CIA) aneurysms undergo endo-
vascular repair, endograft limb extension into the external
iliac artery (EIA) is often necessary. Internal iliac artery
(IIA) is usually embolized to prevent endoleak. However
IIA embolization is associated with longer operative time.
It has been our practice not to routinely coil embolize IIA.
The purpose of this study is to review long term outcomes
with this approach.
Methods: Between April 1997 and June 2010 117
patients (111 men; mean age 70.8 years, range 45-92)
underwent endovascular AAA repair and had IIA coverage
without coil embolization, unilateral in 112 and bilateral in
5 cases. Postoperative computed tomography (CT) scan-
ning was performed at 1, 6, 12 months, and yearly
thereafter.
Results: Preoperative AAA size was a mean 62 mm
(range 35-120), and mean CIA diameter was 37 mm
(range 20-80).Primary technical success was achieved in
108 patients (93.1%). Thirty day mortality was 0.8%
(1/116 patients). A patient presented gluteal skin necro-
sis (0.8%) and 15 buttock claudication (12.9%). Patients
were followed up for 34  31 months (range 1-130), 23
of them for more than 60 months. During follow up 39
patients died (33.3%), in three, death was AAA-related
(including 30-day mortality). Cumulative proportion of
survival was 93%, 84%, 71%, 59%, 53% at 1, 2, 3, 4 and 5
years respectively. Secondary interventions were per-
formed in 19 of 116 patients (16.3%), including three
conversions for failed endografts. Kaplan-Meier esti-
mates revealed freedom from reintervention of 91%,
90%, 83%, 81% and 75% at 1, 2, 3, 4 and 5 years
respectively. Ten patients (8.5%) presented a type II
endoleak during follow up.
Conclusions: Stent-graft coverage of the IIA without
coil embolization is a safe and effective adjunct during the
treatment of aortoiliac aneurysms, with a low incidence of
postoperative complications and reinterventions and ac-
ceptable mid and long term results.
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Objectives: This study is designed to review our early
andmid-term experience with Hybrid TEVAR for complex
aortic pathology.
Methods: We retrospectively reviewed the prospec-
tively recorded data on our series of high risk patients who
had hybrid thoracic aortic repair at our institution. 26
patients underwent a hybrid aortic repair (Median age 72;
range:42-85 years, 65% men) between June 2004 and July
2010. Survival from all-cause death was determined from
the Social Security Death Index.
Results: Primary technical success was achieved in all
the cases. Overall 31 bypasses were performed for aortic
arch debranching (n18) and 21 for visceral(n8), fol-
lowed by TEVAR. 20(77%) hybrid procedures were staged.
Hybrid TEVAR with Aortic Visceral (Distal)debranching: Inflow
and Recipient Vessels. SMA: Superior Mesenteric Artery
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6(23%) procedures were performed emergently. 20(77%)
patients had Thoracic aortic aneurysm (mean diameter 6.7
cm), 2(8%) had penetrating aortic ulcer and 6 (23%) had an
isolated or concomitant aortic dissection. Iliac retroperitoneal
conduit was used in 8(30%) and spinal protection in 14(54%).
There was no perioperative and in hospital mortality. Overall
morbidity was 22%; respiratory failure in 2(8 %), transient
ischemic attack in 2(8 %), renal failure requiring hemodialysis
in 2(8%) patient. None of the patients experienced spinal cord
ischemia or myocardial infarction. One year mortality was
15%(n4). All causemortality over amedian followup period
of 28 months(range 3-77 months)was 27%. 28 of 29 grafts
were patent in postoperative computed tomography angiog-
raphy. 10% developed Type I endoleak with no aneurysm
related death, stent migration or morbidity related to visceral
revascularization.Therewas nodifference between staged and
non-staged hybrid procedures.
Hybrid TEVAR Patient Characteristics
Patient Characteristics n  26
Symptomatic at Presentation n  14 (54%)
ASA 3 n  10 (38%)
ASA 4 n  15 (58%)
Patients with COPD n  10 (38%)
Patients with Coronary Artery Disease n  17 (65%)
Patients with Prior Aortic Surgery n  11 (42%)
Patients with 3 or more co-morbidities n  22 (85%)
Aortic Arch Debranching (Number of patients) n  18 (69%)
Visceral Debranching (Number of patients) n  8 (31%)
Mean SVS Score 8.2  3.9
Angiogram showing thoracoabdominal Aortic Aneurysm involv-
ing visceral arteries (Left) Completion Angiogram after deploy-
ment of TAG endograft showing patent bypass grafts to Celiac
Axis, Superior Mesenteric Artery and Right Renal Artery (Right)
and exclusion of the Aneurysm. Shown is a 4 years post operative three-dimensional, surface-
shaded rendering of a completed Visceral hybrid. Note the endo-
vascular stents covering the distal descending thoracic and abdom-
inal aorta. A reversed trifurcated graft originates from Distal
abdominal aorta to the right renal artery, superior mesenteric
artery and the hepatic artery.
Hybrid TEVAR with Aortic Visceral (Distal)debranching: Inflow
and Recipient Vessels. SMA: Superior Mesenteric Artery.
Completion angiography after stent grafting in a patient that
underwent arch debranching shows the patency of retropharyngeal
Right Common Carotid to Left Common Carotid bypass and Left
Common Carotid to Left Subclavian Bypass Grafts and the exclu-
sion on the aneurysm.
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Conclusions: The mid-term results of hybrid aortic
TEVAR in high risk patients suggest that it can be safely
performed with an acceptable post-operative morbidity and
mortality. Long term follow up and larger series are re-
quired to evaluate the durability of this modality.
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Objectives: Hospitals across the country differ in their
ability to provide endovascular treatment for ruptured ab-
dominal aortic aneurysms (rAAA). As a result, stable pa-
tients may require transfer for more specialized care. We
analyzed short-term clinical outcomes in transferred pa-
tients undergoing open and endovascular procedures for
rAAA.
Methods: Patients with rAAA transferred from another
hospital in the HCUP-Nationwide Inpatient Sample,
2002-7 were identified. Patient demographic and clinical
variables, and physician/hospital characteristics were ana-
lyzed. In-hospital complications and mortality following
open and endovascular procedures were compared using
2.Multivariate logistic regression was used to examine the
effect of procedure type in transferred rAAA patients.
Results: 3587 patients presented with rAAAs, of which
395 were transferred from another hospital. No significant
difference was found in Charlson comorbidity between the
2 groups. rAAA patients were more likely transferred to
urban (95% vs 92%), teaching (79% vs 47%), and high
volume hospitals (62% vs 37%), and receive endovascular
treatment (20% vs 12%), all p0.01. All transferred patients
showed lower mortality (33% vs 41%, p0.001), but no
difference in complications (75% vs 76%) when compared
with nontransferred patients. Transferred patients under-
going endovascular procedures compared to those under-
going open procedures had lower mortality (18% vs 37%)
and complication rates (66% vs 79%), both p0.05. On
multivariate analysis of all transferred patients, open proce-
dure type was associated with higher mortality and higher
complication rates, both p0.01.
Conclusions: To our knowledge, this is the largest
study to date analyzing short-term clinical outcomes in
transferred patients treated for rAAA. Patients stable
enough for transfer undergoing endovascular repair have
superior short term clinical outcomes versus those under-
going open repair. This may have important implications
for the health care utilization of patients with rAAA.
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Objectives: Repair of thoracoabdominal aortic aneu-
rysms (TAAA) is uncommon. Studies using national data
report mortality rates of 20% while single institution studies
report 5-8% mortality. Clinical trials are currently evaluat-
ing branched and fenestrated endografts. The purpose of
this study is to establish a benchmark for future compari-
sons with endovascular trials using open repair of TAAA in
the National Surgical Quality Improvement Program
(NSQIP) database.
Methods: We identified all patients undergoing open
repair of intact TAAA in NSQIP 2005-2008 using CPT
and ICD-9 codes. We analyzed demographic and comor-
bidity characteristics as well as 30 day mortality and post-
operative complications. Predictors of morbidity and mor-
tality were also identified.
Results: 254 patients underwent open repair of intact
TAAA. Mean age was 70.0 years, 61.0% were male, and
90.2% were white. Comorbidities included hypertension
(85.4%), COPD (29.1%), stroke (10.2%), diabetes (9.1%),
and peripheral vascular disease (8.3%). Mean preoperative
creatinine level was 1.29  0.77 mg/dl. Thirty-day mor-
tality was 10.6%. Postoperative complications occurred in
54.7% of patients. Pulmonary complications were the most
common: failure to wean from ventilator (43.4%), pneu-
monia (28.4%), and reintubation (14.2%). Acute renal fail-
ure requiring dialysis was present in 11.8% of patients. On
multivariate analysis age  70 years was predictive of mor-
tality, OR 6.7 (2.3-20.3, p  0.001). Preoperative creati-
nine level ( 1.40 mg/dl) was predictive of postoperative
renal failure, OR 2.4 (1.1-5.3, p0.04), but not predictive
of mortality, OR 0.85 (0.3-2.2, p0.73).
Conclusions: In this study of NSQIP hospitals that
perform open TAAA repair, the 30 day mortality rate of
10.6% is approaching those seen in single institution stud-
ies. However, morbidity and mortality after open TAAA
repair remain high suggesting the need for less invasive
procedures.
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